69628-30-4

Basic information

• Product Name: 11-[(2,4-dimethylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one hydrochloride
• CAS NO: 69628-30-4
• Molecular Formula: C₂₀H₂₄ClN₅O₂
• Molecular Weight: 401.8899
• Mol File: 69628-30-4.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 543.5°C at 760 mmHg
• Flash Point: 282.5°C
• Vapor Pressure: 7.13E-12mmHg at 25°C
• CAS DataBase Reference: 11-[(2,4-dimethylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 11-[(2,4-dimethylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one hydrochloride(69628-30-4)
• EPA Substance Registry System: 11-[(2,4-dimethylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one hydrochloride(69628-30-4)

Safety Data

• Hazardous Substances Data: 69628-30-4(Hazardous Substances Data)

Usage

Chemical class

Benzodiazepine

Salt form

Hydrochloride

Psychoactive properties

Acts as a central nervous system depressant and anxiolytic

Medical uses

Treating anxiety disorders, insomnia, and seizure disorders

Mechanism of action

Enhances the effects of gamma-aminobutyric acid (GABA) in the body

GABA function

Calms the brain and nerves

Precaution

Should be used under medical supervision

Potential risks

Habit-forming, may cause dependence and withdrawal symptoms

Appearance

Crystalline solid

Solubility

Soluble in water and some organic solvents

Stability

Stable under normal conditions, but sensitive to light and heat

Dosage

Varies depending on the specific medical condition and patient's individual needs

Administration

Oral, typically in tablet or capsule form

Half-life

Varies depending on the specific benzodiazepine compound, typically ranging from a few hours to several days

Metabolism

Primarily metabolized in the liver by the cytochrome P450 system

Excretion

Mainly eliminated through the kidneys in the form of metabolites

Drug interactions

May interact with other central nervous system depressants, alcohol, and certain medications

Side effects

Can include drowsiness, dizziness, and impaired coordination, among others

Withdrawal symptoms

May include anxiety, insomnia, and seizures if discontinued abruptly after long-term use

Upstream product

• 28797-48-0 11-(chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one 
• 22317-01-7 1,3-dimethyl-piperazine 

Relevant articles and documents

11-(Piperazino-acetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-ones and salts thereof

Compounds of the formula STR1 wherein R1 is alkyl of 3 to 12 carbon atoms; unsaturated aliphatic hydrocarbyl of 3 to 20 carbon atoms comprising 1 to 3 double bonds and/or one triple bond; phenyl(alkyl of 2 to 4 carbon atoms); methylenedioxybenz